These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29262633)

  • 1. Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun.
    Huang G; Pan J; Ye Z; Fang B; Cheng W; Cao Z
    Oncotarget; 2017 Nov; 8(61):104206-104215. PubMed ID: 29262633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
    Liu Y; Niu Z; Lin X; Tian Y
    Cancer Gene Ther; 2017 May; 24(5):208-214. PubMed ID: 28281524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2.
    Tian L; Zhang J; Ren X; Liu X; Gao W; Zhang C; Sun Y; Liu M
    Oncotarget; 2017 Oct; 8(45):79023-79033. PubMed ID: 29108284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.
    Liu S; Dong H; Dai H; Liu D; Wang Z
    Oncol Lett; 2018 Jun; 15(6):10077-10083. PubMed ID: 29928377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-216b inhibits heat stress-induced cell apoptosis by targeting Fas in bovine mammary epithelial cells.
    Cai M; Hu Y; Zheng T; He H; Xiao W; Liu B; Shi Y; Jia X; Chen S; Wang J; Lai S
    Cell Stress Chaperones; 2018 Sep; 23(5):921-931. PubMed ID: 29730848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer.
    Vu T; Yang S; Datta PK
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32668597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the P2X7R by microRNA-216b in human breast cancer.
    Zheng L; Zhang X; Yang F; Zhu J; Zhou P; Yu F; Hou L; Xiao L; He Q; Wang B
    Biochem Biophys Res Commun; 2014 Sep; 452(1):197-204. PubMed ID: 25078617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.
    Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z
    Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
    Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.
    Han LP; Fu T; Lin Y; Miao JL; Jiang QF
    Tumour Biol; 2016 Jan; 37(1):291-8. PubMed ID: 26201895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.
    Dluzen DF; Sutliff AK; Chen G; Watson CJ; Ishmael FT; Lazarus P
    J Pharmacol Exp Ther; 2016 Oct; 359(1):182-93. PubMed ID: 27474751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel.
    Chen K; Shi W
    Tumour Biol; 2016 Aug; 37(8):10539-44. PubMed ID: 26852748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
    Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
    Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells.
    Dolapçi İB; Noyan S; Polat AY; Gürdal H; Dedeoğlu BG
    Turk J Biol; 2023; 47(3):199-207. PubMed ID: 37529418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
    Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
    Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
    Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L
    Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
    Deng M; Liu JF; Gu YX; Zheng GP; He ZM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
    Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.